The Asia-Pacific proteomics market is projected to register a CAGR of 15.95% during the forecast period, 2022-2030, and is set to reach a revenue of $19550.03 million by 2030.
ASIA-PACIFIC PROTEOMICS MARKET FORECAST 2022-2030
Asia-Pacific Proteomics Market by Components (Reagents (Immunoassay, Spectroscopy, Microarray, X-ray Crystallography, Electrophoresis, Chromatography, Protein Fractionation Reagents), Instruments (Protein Microarray, Spectroscopy, Chromatography, Surface Plasmon Resonance, Electrophoresis, Protein Fractionation Reagents, X-ray Crystallography), Services) Market by Application (Drug Discovery, Disease Diagnosis, Other Applications) by Geography
The Asia-Pacific proteomics market is projected to register a CAGR of 15.95% during the forecast period, 2022-2030, and is set to reach a revenue of $19550.03 million by 2030.
Asia encompasses a dense population base for different groups, races, and ethnicities. This benefits the researchers and scientists since it enables opportunities to conduct studies and their impact on people with different gene codes. This further aids in identifying and establishing region-specific characterization. Such aspects propel the proteomics market growth.
To know more about this report, request a free sample copy
The Asia-Pacific proteomics market growth assessment includes the analysis of Vietnam, Thailand, South Korea, India, Indonesia, Japan, Australia & New Zealand, China, and Rest of Asia-Pacific. In China, the developments and initiatives by research institutes and scientists contribute to market growth. The research institutes focus on research, studies, works, and proteomics projects. Also, recently, scientists identified the alteration of an enzyme that consumers itaconate in the TCA cycle.
In South Korea, the government initiatives in terms of acknowledging the importance of precision or personalized medicine (PM) and including it as part of its nine National Strategic Projects enable market growth. This is also attributed to the transition of healthcare and medicine, propelled by the high investments in molecular biology. Korea’s first large-scale public project, the Ulsan 10,000 Genome Project, aims to map the complete genomic diversity of Koreans through rare genetic mutations detection, providing well-annotated full genome information, and the construction of a reference database of genomic variation.
In countries like Vietnam, the healthcare sector development is accredited to the county’s continuous economic development, the growing demand for high-quality healthcare services, and the growing middle-class population. Also, there have been increased investments to expand and upgrade their facilities, offer better services, and enhance operational efficiency. As a result, better disease diagnosis capabilities and medical research are needed. Such factors, along with the rising prioritization of life sciences and healthcare development, are expected to increase the application and usage of proteomics.
The segmentation analysis of the Asia-Pacific proteomics market includes application and components. The components segment includes disease diagnosis, drug discovery, and other applications.
Disease diagnosis is defining the nature of a disease and distinguishing it from other probable diseases. Certain diseases are identified by looking at the bio-marker. It refers to disease-related proteins that can be used to monitor the activity of a disease, its development, and prognosis. In medicine, a biomarker is a traceable substance that is introduced into an organism to examine organ function.
Furthermore, with the altering protein expression during disease conditions in biological pathways, evaluating these altered proteins in blood, urine, tissue, or other biological samples can provide disease indicators. Proteomics technology is vastly used in molecular medicine for biomarker discovery. Proteomics can identify invaluable disease-specific biomarkers by assessing a global protein profiling in the body fluids.
Some of the key companies in the Asia-Pacific proteomics market are Promega Corporation, Sengenics, PerkinElmer Inc, MS Bioworks, etc.
Sengenics is a functional proteomics company. It offers services and products needed for protein research, studies, and analysis. The company majorly operates in the United States, South Korea, Japan, and China, with headquarters in Kuala Lumpur, Malaysia.
One of its key products, i-Ome® Protein Array – Service & Kits, has more than 1600 correctly folded and functional human proteins relevant to neurological & autoimmune diseases and cancer.
Report Synopsis:
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Application and Components |
| Countries Analyzed | Vietnam, Thailand, South Korea, India, Indonesia, Japan, Australia & New Zealand, China, and Rest of Asia-Pacific |
| Companies Analyzed | Agilent Technologies Inc, Biognosys AG, Bio-Rad Laboratories, Bruker Corporation, Creative Proteomics, Danaher Corporation, Fios Genomics, Japan Electron Optics Laboratory Co Ltd (Joel), MS Bioworks, PerkinElmer Inc, Promega Corporation, Sengenics, Shimadzu, Thermo Fisher Scientific Inc, Waters Corporation |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- ADVANCES IN PROTEOMICS STUDY AND ITS WIDE-SCALE APPLICATIONS
- TECHNOLOGICAL ADVANCEMENTS
- KEY RESTRAINTS
- HIGHLY EXPENSIVE SERVICES AND INSTRUMENTATION
- LOW UNIFIED EFFORTS AND INITIATIVES BY GOVERNMENTS AND OTHER ORGANISATIONS
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON PROTEOMICS MARKET INDUSTRY
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY BUYING CRITERIA
- MARKET BY COMPONENTS
- REAGENTS
- IMMUNOASSAY
- SPECTROSCOPY
- MICROARRAY
- X-RAY CRYSTALLOGRAPHY
- ELECTROPHORESIS
- CHROMATOGRAPHY
- PROTEIN FRACTIONATION REAGENTS
- INSTRUMENTS
- PROTEIN MICROARRAY
- SPECTROSCOPY
- MASS SPECTROMETRY
- NMR SPECTROMETRY
- CHROMATOGRAPHY
- HPLC SYSTEMS
- AFFINITY CHROMATOGRAPHY
- SUPERCRITICAL FLUID CHROMATOGRAPHY
- ION CHROMATOGRAPHY
- SURFACE PLASMON RESONANCE
- ELECTROPHORESIS
- PROTEIN FRACTIONATION REAGENTS
- X-RAY CRYSTALLOGRAPHY
- SERVICES
- REAGENTS
- MARKET BY APPLICATION
- DRUG DISCOVERY
- DISEASE DIAGNOSIS
- OTHER APPLICATION
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS
- COMPANY PROFILES
- AGILENT TECHNOLOGIES INC
- BIOGNOSYS AG
- BIO-RAD LABORATORIES
- BRUKER CORPORATION
- CREATIVE PROTEOMICS
- DANAHER CORPORATION
- FIOS GENOMICS
- JAPAN ELECTRON OPTICS LABORATORY CO LTD (JOEL)
- MS BIOWORKS
- PERKINELMER INC
- PROMEGA CORPORATION
- SENGENICS
- SHIMADZU
- THERMO FISHER SCIENTIFIC INC
- WATERS CORPORATION
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – PROTEOMICS
TABLE 2: ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC PROTEOMICS MARKET, BY REAGENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC PROTEOMICS MARKET, BY REAGENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC PROTEOMICS MARKET, BY INSTRUMENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC PROTEOMICS MARKET, BY INSTRUMENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC PROTEOMICS MARKET, BY SPECTROSCOPY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC PROTEOMICS MARKET, BY SPECTROSCOPY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC PROTEOMICS MARKET, BY CHROMATOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC PROTEOMICS MARKET, BY CHROMATOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: KEY PLAYERS IN ASIA-PACIFIC PROTEOMICS MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: ASIA-PACIFIC PROTEOMICS MARKET, GROWTH POTENTIAL, BY COMPONENTS, IN 2021
FIGURE 7: ASIA-PACIFIC PROTEOMICS MARKET, BY REAGENTS, 2022-2030 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC PROTEOMICS MARKET, GROWTH POTENTIAL, BY REAGENTS, IN 2021
FIGURE 9: ASIA-PACIFIC PROTEOMICS MARKET, BY IMMUNOASSAY, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC PROTEOMICS MARKET, BY MICROARRAY, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC PROTEOMICS MARKET, BY INSTRUMENTS, 2022-2030 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC PROTEOMICS MARKET, GROWTH POTENTIAL, BY INSTRUMENTS, IN 2021
FIGURE 18: ASIA-PACIFIC PROTEOMICS MARKET, BY PROTEIN MICROARRAY, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC PROTEOMICS MARKET, GROWTH POTENTIAL, BY SPECTROSCOPY, IN 2021
FIGURE 21: ASIA-PACIFIC PROTEOMICS MARKET, BY MASS SPECTROMETRY, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC PROTEOMICS MARKET, BY NMR SPECTROMETRY, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC PROTEOMICS MARKET, GROWTH POTENTIAL, BY CHROMATOGRAPHY, IN 2021
FIGURE 25: ASIA-PACIFIC PROTEOMICS MARKET, BY HPLC SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC PROTEOMICS MARKET, BY AFFINITY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC PROTEOMICS MARKET, BY SUPERCRITICAL FLUID CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC PROTEOMICS MARKET, BY ION CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC PROTEOMICS MARKET, BY SURFACE PLASMON RESONANCE, 2022-2030 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 33: ASIA-PACIFIC PROTEOMICS MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC PROTEOMICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 35: ASIA-PACIFIC PROTEOMICS MARKET, BY DRUG DISCOVERY, 2022-2030 (IN $ MILLION)
FIGURE 36: ASIA-PACIFIC PROTEOMICS MARKET, BY DISEASE DIAGNOSIS, 2022-2030 (IN $ MILLION)
FIGURE 37: ASIA-PACIFIC PROTEOMICS MARKET, BY OTHER APPLICATION, 2022-2030 (IN $ MILLION)
FIGURE 38: ASIA-PACIFIC PROTEOMICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 39: CHINA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: JAPAN PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: INDIA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: SOUTH ASIA-PACIFIC PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDONESIA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: THAILAND PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: VIETNAM PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: AUSTRALIA & NEW ZEALAND PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: REST OF ASIA-PACIFIC PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY COMPONENTS
- REAGENTS
- IMMUNOASSAY
- SPECTROSCOPY
- MICROARRAY
- X-RAY CRYSTALLOGRAPHY
- ELECTROPHORESIS
- CHROMATOGRAPHY
- PROTEIN FRACTIONATION REAGENTS
- INSTRUMENTS
- PROTEIN MICROARRAY
- SPECTROSCOPY
- MASS SPECTROMETRY
- NMR SPECTROMETRY
- CHROMATOGRAPHY
- HPLC SYSTEMS
- AFFINITY CHROMATOGRAPHY
- SUPERCRITICAL FLUID CHROMATOGRAPHY
- ION CHROMATOGRAPHY
- SURFACE PLASMON RESONANCE
- ELECTROPHORESIS
- PROTEIN FRACTIONATION REAGENTS
- X-RAY CRYSTALLOGRAPHY
- SERVICES
- REAGENTS
- MARKET BY APPLICATION
- DRUG DISCOVERY
- DISEASE DIAGNOSIS
- OTHER APPLICATION
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.